Table 1.
Overview of experimental groups in Experiment 1 and 2.
| Experiment 1 | |||
|---|---|---|---|
| Group | N | CFA | Treatment |
| Control | 6 males and 6 females | − | Isotonic saline 0.9% s.c., twice daily |
| Vehicle | 6 males and 6 females | + | Isotonic saline 0.9% s.c., twice daily |
| CAR s.c. | 6 males and 6 females | + | Carprofen 5.0 mg/kg s.c., once daily and isotonic saline 0.9% s.c., as second injection |
| BUP s.c. | 6 males and 6 females | + | Buprenorphine 0.1 mg/kg, s.c., twice daily |
| BUP p.o. vol. | 6 males and 6 females | + | Buprenorphine 0.8 mg/kg p.o. vol., twice daily |
| Experiment 2 | |||
|---|---|---|---|
| Group | N | CFA | Treatment |
| Vehicle | 6 males and 6 females | + | Isotonic saline 0.9% s.c., twice daily |
| 6 males and 6 females | + | Nut paste, twice daily | |
| BUP s.c. | 6 males and 6 females | + | Buprenorphine 0.10 mg/kg s.c., twice daily |
| 6 males and 6 females | + | Buprenorphine 0.15 mg/kg s.c., twice daily | |
| BUP p.o. vol. | 6 males and 6 females | + | Buprenorphine 1.0 mg/kg p.o. vol., twice daily |
| 6 males and 6 females | + | Buprenorphine 3.0 mg/kg p.o. vol., twice daily | |